Further in vivo studies are needed to ascertain whether decreased SNO-RhoA and SNO-actin contribute to DKD progression and to evaluate the effect of NO donors on S-nitrosylation of Myo9A, RhoA and actin. The gene discussed is MYO9A; the disease is diabetic kidney disease.